Hepatic veno-occlusive disease after tranexamic acid administration in oatients undergoing allogeneic hematopoietic stem cell transplantation

Takehiko Mori, Yoshinobu Aisa, Takayuki Shimizu, Rie Yamazaki, Ai Mihara, Tomoharu Yajima, Toshifumi Hibi, Yasuo Ikeda, Shinichiro Okamoto

研究成果: Article査読

8 被引用数 (Scopus)

抄録

Tranexamic acid is one of the widely used antifibrinolytic agents. In spite of its effective inhibitory activity against plasminogen, thromboembolic adverse events caused by tranexamic acid are rare. We encountered three recipients of allogeneic hematopoietic stem cell transplantation (HSCT) who developed hepatic veno-occlusive disease (VOD) shortly after the administration of tranexamic acid. Hepatic VOD was resolved completely in all patients with the discontinuation of the drug, and with supportive measures with or without intravenous tissue plasminogen activator administration. These findings suggest that administration of tranexamic acid could be one of the possible risk factors for developing hepatic VOD in HSCT recipients.

本文言語English
ページ(範囲)838-839
ページ数2
ジャーナルAmerican journal of hematology
82
9
DOI
出版ステータスPublished - 2007 9月 1

ASJC Scopus subject areas

  • 血液学

フィンガープリント

「Hepatic veno-occlusive disease after tranexamic acid administration in oatients undergoing allogeneic hematopoietic stem cell transplantation」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル